Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Billy_Boyle
|
| gptkbp:focusesOn |
cancer detection
digestive disease detection lung disease detection |
| gptkbp:foundedIn |
2004
|
| gptkbp:founder |
gptkb:Alastair_Taylor
gptkb:Billy_Boyle gptkb:David_Perry |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| gptkbp:industry |
medical diagnostics
|
| gptkbp:notableProduct |
gptkb:Breath_Biopsy_platform
|
| gptkbp:parentCompany |
gptkb:Owlstone_Inc.
|
| gptkbp:specializesIn |
early disease detection
breath biopsy volatile organic compound analysis |
| gptkbp:website |
https://www.owlstonemedical.com/
|
| gptkbp:bfsParent |
gptkb:Wellcome_Trust_Sanger_Institute
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Owlstone Medical
|